| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
6 companies
Adar1 Capital Management, LLC is a 10% Owner at TENX, with reported holdings spanning 6 companies. Recent filings cover 63 purchases and 3 sales. Those positions are worth an estimated $32.1M at current prices.
Our model assigns Adar1 Capital Management, LLC a strong insider score of 78/100, based on 6 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +73.6%.
Adar1 Capital Management, LLC's largest disclosed position is in RLYB as 10% Owner, worth about $12.9M. Net of sales, the recent Form 4 record there shows accumulation of 302,473 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | NXTC Nextcure, Inc. | 10% Owner | Buy | 17,608 | $4.98 | $87,712.76 | +4.7% | -0.8% | - | |
| Jul 15, 2026 | INM Inmed Pharmaceuticals Inc. | 10% Owner | Buy | 1,000 | $1.56 | $1,555.00 | +0.1% | -16.4% | - | |
| May 19, 2026 | INM Inmed Pharmaceuticals Inc. | 10% Owner | Buy | 468,551 | $1.54 | $721,547.89 | +141.4% | -8.7% | - | |
| May 19, 2026 | RLYB Rallybio Corporation | 10% Owner | Buy | 16,209 | $13.98 | $226,563.18 | +1.8% | +19.8% | - | |
| May 15, 2026 | RLYB Rallybio Corporation | 10% Owner | Buy | 79,559 | $13.99 | $1,112,976.94 | +9.6% | +18.6% | - | |
| May 12, 2026 | RLYB Rallybio Corporation | 10% Owner | Buy | 50,800 | $14.00 | $711,054.88 | +6.5% | +18.4% | - | |
| May 5, 2026 | RLYB Rallybio Corporation | 10% Owner | Buy | 155,905 | $13.97 | $2,178,668.31 | +25.0% | +11.7% | - | |
| Oct 15, 2025 | KROS Keros Therapeutics, Inc. | 10% Owner | Sell | 5,389,264 | $17.75 | $95,659,436.00 | -100% | +34.6% | -23.4% | |
| Apr 9, 2025 | KROS Keros Therapeutics, Inc. | 10% Owner | Buy | 934,258 | $10.13 | $9,464,512.25 | +27.0% | +34.7% | +20.9% | |
| Aug 12, 2024 | PVLA Palvella Therapeutics, Inc. | 10% Owner | Buy | 6,000 | $15.39 | $92,325.90 | +66.2% | +0.5% | +171.9% |